Generation Bio Co.
NASDAQ:GBIO
2.16 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 5.904 | 0 | 0 | 0 | 0 | 0.036 |
| Cost of Revenue
| 5.263 | 5.13 | 4.532 | 3.432 | 1.864 | 0 |
| Gross Profit
| 0.641 | -5.13 | -4.532 | -3.432 | -1.864 | 0.036 |
| Gross Profit Ratio
| 0.109 | 0 | 0 | 0 | 0 | 1 |
| Reseach & Development Expenses
| 93.617 | 96.718 | 85.247 | 58.532 | 50.134 | 28.152 |
| General & Administrative Expenses
| 50.85 | 44.464 | 33.854 | 22.582 | 12.168 | 9.178 |
| Selling & Marketing Expenses
| 23.301 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 50.85 | 44.464 | 33.854 | 22.582 | 12.168 | 9.178 |
| Other Expenses
| -93.617 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 144.467 | 141.182 | 119.101 | 81.114 | 62.302 | 37.33 |
| Operating Income
| -138.563 | -141.182 | -119.101 | -81.114 | -62.302 | -37.294 |
| Operating Income Ratio
| -23.469 | 0 | 0 | 0 | 0 | -1,035.944 |
| Total Other Income Expenses Net
| 11.951 | 4.543 | -0.05 | 0.591 | 0.985 | 1.491 |
| Income Before Tax
| -126.612 | -136.639 | -119.151 | -80.523 | -61.317 | -35.803 |
| Income Before Tax Ratio
| -21.445 | 0 | 0 | 0 | 0 | -994.528 |
| Income Tax Expense
| 5.095 | -4.543 | -4.482 | -4.023 | -0.985 | 1.491 |
| Net Income
| -126.612 | -132.096 | -114.669 | -76.5 | -60.332 | -35.803 |
| Net Income Ratio
| -21.445 | 0 | 0 | 0 | 0 | -994.528 |
| EPS
| -1.96 | -2.27 | -2.04 | -2.81 | -1.31 | -1.82 |
| EPS Diluted
| -1.96 | -2.27 | -2.04 | -2.81 | -1.31 | -1.82 |
| EBITDA
| -133.3 | -141.182 | -119.101 | -81.114 | -60.438 | -36.947 |
| EBITDA Ratio
| -22.578 | 0 | 0 | 0 | 0 | -1,026.306 |